The Rat Diabetes Susceptibility Locus Iddm4 and at Least One Additional Gene Are Required for Autoimmune Diabetes Induced by Viral Infection
http://www.100md.com
糖尿病学杂志 2005年第4期
1 Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, Pennsylvania
2 Department of Medicine, University of Massachusetts, Worcester, Massachusetts
ABSTRACT
BBDR rats develop autoimmune diabetes only after challenge with environmental perturbants. These perturbants include polyinosinic:polycytidylic acid (poly I:C, a ligand of toll-like receptor 3), agents that deplete regulatory T-cell (Treg) populations, and a noneC-cell cytopathic parvovirus (Kilham rat virus [KRV]). The dominant diabetes susceptibility locus Iddm4 is required for diabetes induced by treatment with poly I:C plus Treg depletion. Iddm4 is penetrant in congenic heterozygous rats on the resistant WF background and is 79% sensitive and 80% specific as a predictor of induced diabetes. Surprisingly, an analysis of 190 (BBDR x WF)F2 rats treated with KRV after brief exposure to poly I:C revealed that the BBDR-origin allele of Iddm4 is necessary but not entirely sufficient for diabetes expression. A genome scan identified a locus on chromosome 17, designated Iddm20, that is also required for susceptibility to diabetes after exposure to KRV and poly I:C (logarithm of odds score 3.7). These data suggest that the expression of autoimmune diabetes is a complex process that requires both major histocompatibility complex genes that confer susceptibility and additional genes such as Iddm4 and Iddm20 that operate only in the context of specific environmental perturbants, amplifying the immune response and the rate of disease progression.
Type 1 diabetes results from inflammatory infiltration of pancreatic islets and selective -cell destruction. It is thought to be caused by environmental factors operating in a genetically susceptible host (1,2). Susceptibility loci include the major histocompatibility complex (MHC), a promoter polymorphism of the insulin gene, and an allelic variant of CTLA4 (3). Among candidate environmental perturbants, viral infection is one of the most likely (4). How genes interact with the environment to transform diabetes susceptibility into overt disease is unknown.
BBDR rats model virus-induced autoimmune diabetes remarkably well (5). They are phenotypically normal and, in clean housing, never develop diabetes. They do, however, become diabetic when challenged with environmental perturbants, including polyinosinic:polycytidylic acid (poly I:C) in combination with depletion of regulatory T-cells (Tregs) (6). Diabetes can also be induced in BBDR rats with Kilham rat virus (KRV), a noneC-cell cytopathic parvovirus (7). Naturally occurring KRV infection induces diabetes in 1% of animals; intentional infection with 107 plaque forming units (PFU) induces diabetes in 30% of BBDR rats (7). Infection with KRV following brief pretreatment with a low, subdiabetogenic dose of poly I:C (1 e/g daily for 3 days) leads to diabetes in 100% of animals (8). The effect is virus specific; H-1, which is 98% sequence identical, uniformly fails to induce diabetes (8).
In analyses of (BBDP x WF) x WF rats, we used poly I:C plus Treg depletion to map a locus on chromosome 4 (Iddm4) with significant linkage to diabetes (6,9), and we recently positioned Iddm4 in a 2.8-cM region (10). The BB- origin allele of Iddm4 is dominant and 79% sensitive and 80% specific as a predictor of diabetes induced by Treg depletion and poly I:C. A radiation hybrid map has assigned Iddm4 to a 6.3-Mb segment between PTN and ZYX at 7q32 in the human genome and to a 5.7-Mb segment between Ptn and Zyx in the mouse genome (11).
We now report a linkage analysis of 190 (BBDR x WF)F2 rats. It reveals that the BBDR-origin allele of Iddm4 is necessary but not entirely sufficient for diabetes expression in response to KRV infection. An additional gene or genes on chromosome 17 are necessary.
RESEARCH DESIGN AND METHODS
BBDR/Wor, WF.Iddm4, and WF.ART2a rats (all RT1u/u, ART2a) were obtained from colonies maintained by us. WF.Iddm4 congenic rats were generated by repetitive (BBDR/Wor x WF) x WF backcrosses using a marker-assisted selection protocol as described (10). They were studied at the N6 generation. WF.ART2a congenic rats were also developed by us and differ from ordinary WF animals in that they express the "a" rather than the "b" allotype of the ART2 T-cell alloantigen on chromosome 1 (10). For simplicity, we refer to them here as WF rats. An F2 intercross was bred from (BBDR x WF)F1 hybrids. Animals were housed in viral antibodyeCfree conditions, confirmed monthly to be serologically free of rat pathogens (10), and maintained in accordance with recommendations in the Guide for the Care and Use of Laboratory Animals (National Academy of Sciences, 1996).
Microsatellite and mapping analyses.
Genomic DNA was prepared as described (10) (online appendix Fig. 3 [available from http://diabetes.diabetesjournals.org]). Microsatellite markers were placed evenly throughout the 20 autosomes. The source of primers and positions of markers on the genetic map are given in online appendix Fig. 3. Primers were end labeled using 32P-ATP, used in a PCR reaction, and resolved by polyacrylamide gel electrophoresis as described (6). The position of markers on the genetic map was established by inspection of the dataset and conventional calculation methods to establish meiotic map distances, which are expressed in centimorgans (cM) or megabases (Mb) according to the rat genome sequence, June 2003 build (available at http://genome.ucsc.edu).
Linkage of diabetes with segregation of BBDR-origin alleles was evaluated by composite interval mapping (CIM) using model 6 of the Zmapqtl program in Windows QTL Cartographer v1.30 (available at statgen.ncsu.edu/qtlcart/cartographer.html). CIM combines classical interval mapping with multiple regression analysis, allowing for more precise quantitative trait loci (QTL) localization than classical interval mapping (12).
Treatment protocols.
KRV-UMass was propagated in normal rat kidney cells grown in Dulbecco’s minimal essential medium. Poly I:C (Sigma, St. Louis, MO) was dissolved in Dulbecco’s PBS, sterile filtered, and stored at eC20°C until used. Contaminating endotoxin concentration was <50 units/mg (Charles River Endosafe, Charleston, SC). In studies of KRV alone, rats of either sex 22eC28 days old were injected intraperitoneally with 107 PFU in a volume of 1 ml. In other experiments, rats 21eC25 days of age of either sex were injected intraperitoneally with poly I:C (1 e/g body wt on 3 consecutive days) and either not treated further or injected on the following day with KRV. Pretreatment with poly I:C was used because it increases the frequency of diabetes in KRV-treated BBDR rats from 30 to 100% (8). Animals were screened three times weekly for glycosuria (Tes-Tape; Eli Lilly, Indianapolis, IN). Diabetes was diagnosed on the basis of a plasma glucose concentration >11.1 mmol/l (OneTouch Ultra Glucometer; LifeScan, Milpitas, CA). For study of insulitis, pancreata were removed, fixed in formalin, and stained with hematoxylin and eosin. Insulitis was graded by a qualified pathologist on a scale of increasing intensity from 0 to 4+ as described (10).
RESULTS
Autoimmune diabetes induced by KRV and TLR3 ligation.
We first confirmed (8) that a significant fraction (41%) of parental BBDR rats become diabetic after infection with KRV alone, that none become diabetic in response to a 3-day course of poly I:C alone, and that 100% become diabetic in response to KRV after poly I:C (Table 1). We also confirmed (13) that WF rats resist diabetes induction in response to either KRV or KRV plus poly I:C (Table 1).
We next tested N6 generation WF.Iddm4 congenic rats (10) for disease susceptibility. To our surprise, we observed WF.Iddm4d rats to be uniformly resistant to diabetes in response to KRV infection either alone or after poly I:C, despite maintaining the expected degree of susceptibility to diabetes after treatment with poly I:C and Treg depletion (Table 1).
Autoimmune diabetes induced by KRV and TLR ligation segregates with Iddm4 and a second locus in (BBDR x WF)F2 rats.
To determine whether Iddm4 acts only in the presence of additional BBDR-origin genes, we generated (BBDR x WF)F1 progeny. We observed that all F1 rats were resistant to KRV alone, but 38% were susceptible to treatment with KRV plus poly I:C. To identify susceptibility genes, we then generated (BBDR x WF)F2 progeny and treated them with KRV plus poly I:C. Diabetes occurred in 59 of 190 animals (31%) in this segregating population and affected both males and females (Table 1). Looking first at the Iddm4 interval, we observed that diabetes occurred almost exclusively in animals with at least one BBDR-origin allele of Iddm4 (58 of 59 diabetic animals, Table 2). The presence of the BBDR allele of Iddm4 was 98% sensitive but only 31% specific in predicting susceptibility to diabetes, implying that at least one gene of BBDR origin is required for the expression of diabetes in response to infection. We therefore performed a genome-wide scan on this F2 cohort. The remaining genome was assessed for linkage using 144 markers on the 20 autosomes (online appendix Fig. 3).
Composite interval analysis of the linkage data is shown in Fig. 1. Iddm4, as expected, showed strong linkage to diabetes (logarithm of odds [LOD] >6.0 at 36 cM on chromosome 4). A second locus on chromosome 17 was linked to diabetes in the F2 population with an LOD score of 3.7. This locus has been designated Iddm20 by the curators of the Rat Genome Database (available at www.rgd.mcw.edu).
To determine the mode of inheritance and the interaction between these two loci, we analyzed the dataset using a life-table analysis. As shown in Fig. 2, the highest likelihood of diabetes onset occurs in animals in which the BBDR-origin allele of Iddm4 is homozygous or heterozygous and Iddm20 is homozygous.
Candidate gene analysis.
The genome-wide scan positioned the Iddm20 locus in a 1-LOD interval bounded by D17Rat61 (at 19.7 Mb) and D17Rat115 (at 27.7 Mb) (available at http://genome.ucsc.edu). To identify candidate genes within this interval, we constructed a preliminary map using the databases at UCSC and Ensembl (available at http://genome.ucsc.edu and http://www.ensembl.org). The genes in the Iddm20 region have their human orthologs on human chromosomes 5, 6, and 9 and on mouse chromosome 13. Of interest is a confirmed mouse diabetes QTL (Idd14) in this homologous region (14,15). Candidate genes in the Iddm20 interval are listed in online appendix Table 4.
Histology.
Histologic analysis of islets revealed nearly complete concordance of insulitis scores with diabetes phenotype. Among the 59 diabetic F2 animals, the mean insulitis score was 3.7 with 49 scored 4+ or end-stage insulitis. In contrast, among 127 nondiabetic rats with technically satisfactory specimens, the mean insulitis score was 0.3 with 111 (87%) being entirely normal and 8 of the remaining 16 exhibiting only 1+ insulitis. Exocrine pancreatitis was absent.
DISCUSSION
These data establish linkage of rat genotype to a form of environmental perturbation—infection—that is potentially important in the pathogenesis of autoimmunity. They confirm that Iddm4 is an exceptionally strong non-MHC determinant of susceptibility to autoimmune diabetes in the rat (6,9eC11). In previous studies of Iddm4, diabetes was induced by chronic treatment with poly I:C plus Treg depletion. The present data now extend the role of Iddm4 in diabetes pathogenesis to virus-induced disease expression. They also illuminate the complexity of environmental interaction with genetic susceptibility. The diabetogenic potential of Iddm4 is readily discernable in congenic rats treated with poly I:C and Treg depletion but is far less apparent in animals treated with KRV plus poly I:C unless additional BBDR genes are present. We have discovered at least one of these genes, designated Iddm20, on chromosome 17.
The Iddm20 interval (online appendix Table 3) contains at least one gene of particular interest: Syk. This gene is involved in T-cell receptoreCdependent signaling pathways and interacts with Cblb (16). This could be important because Cblb is a known rat diabetes susceptibility gene (17). Loss of function mutations in Cblb lead to activation of autoreactive diabetogenic T-cells in the absence of full costimulation (17).
Iddm20, like Iddm4, appears to act as a genetic dominant with incomplete penetrance. There is clear disease-promoting activity in the Iddm20 heterozygote. In the poly I:C plus Treg system, 70% of both WF.Iddm4d/w heterozygotes and WF.Iddm4d/d homozygotes become diabetic (10). In the KRV plus poly I:C model, homozygosity for diabetogenic alleles at the Iddm20 locus increases the penetrance of diabetes in Iddm4d/d rats from 25% (in Iddm20w/w animals) to 56%, and it increases penetrance in Iddm4d/w rats from 11 to 59%. We therefore regard Iddm20 as a modifier of the Iddm4 locus.
The mechanisms by which poly I:C and KRV infection act to induce diabetes in genetically susceptible rats are not yet known. We speculate that Iddm4, Iddm20, or both define a strain-specific response of BBDR rats to KRV infection. KRV is known to infect lymphocytes in the pancreatic lymph nodes (but not the islets) of BBDR rats (18). More recent studies have revealed that KRV also causes a decrease in splenic CD4+CD25+ Treg cells in both BBDR and normal WF rats (8). In adult LEW rats, KRV-UMass infection is associated with several potentially important effects on both CD4+ and CD8+ T-cell populations (19) but whether allelic variations in Iddm4 or Iddm20 regulate those responses is not yet known. By itself, KRV infection typically induces diabetes in 30eC40% of BBDR/Wor rats (8). Pretreatment poly I:C, at a dose that is itself incapable of inducing disease, dramatically increases the penetrance of diabetes (8). The mechanism of this synergy is not clear but is likely to relate to innate immunity because poly I:C is a ligand of toll-like receptor 3 and a potent inducer of type I interferon production by various cells (20) and interleukin-1 production by monocytes (21). It also activates natural killer cells (22) and B-cells (23). In rats, it has been shown that interferon production in response to poly I:C varies substantially in different inbred strains (24), an effect that is presumably genetically determined. It will be of interest to determine whether Iddm4 and/or Iddm20 is a determinant of the magnitude of the immune response to poly I:C.
ACKNOWLEDGMENTS
This study was supported in part by grants DK49106 (to D.L.G., J.P.M., and E.P.B.), DK 36024 (to D.L.G.), DK25306 (to J.P.M.), and Center Grant DK32520 from the National Institutes of Health. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.
We thank Dr. Michael Appel for scoring histology specimens, Michael Bates and Deborah Mullen for technical assistance, and Dennis Guberski for logistic support.
FOOTNOTES
Additional information for this article can be found in an online appendix at http://diabetes.diabetesjournals.org.
KRV, Kilham rat virus; MHC, major histocompatibility complex; poly I:C, polyinosinic:polycytidylic acid; QTL, quantitative trait loci; Treg, regulatory T-cell
REFERENCES
Hawa MI, Beyan H, Buckley LR, Leslie RDG: Impact of genetic and non-genetic factors in type 1 diabetes. Am J Med Genet115 :8 eC17,2002
kerblom HK, Vaarala O, Hyty H, Ilonen J, Knip M: Environmental factors in the etiology of type 1 diabetes. Am J Med Genet115 :18 eC29,2002
Anjos S, Polychronakos C: Mechanisms of genetic susceptibility to type I diabetes: beyond HLA. Mol Genet Metab81 :187 eC195,2004
Yoon J-W, Jun H-S: Role of viruses in the pathogenesis of type 1 diabetes mellitus. In Diabetes mellitus: A fundamental and clinical text. LeRoith D, Taylor SI, Olefsky JM, Eds. Philadelphia, Lippincott Williams & Wilkins,2004 , p.575 eC590
Mordes JP, Bortell R, Blankenhorn EP, Rossini AA, Greiner DL: Rat models of type 1 diabetes: Genetics, environment, and autoimmunity. ILAR J45 :278 eC291,2004
Martin A-M, Maxson MN, Leif J, Mordes JP, Greiner DL, Blankenhorn EP: Diabetes-prone and diabetes-resistant BB rats share a common major diabetes susceptibility locus, iddm4: additional evidence for a "universal autoimmunity locus" on rat chromosome 4. Diabetes48 :2138 eC2144,1999
Guberski DL, Thomas VA, Shek WR, Like AA, Handler ES, Rossini AA, Wallace JE, Welsh RM: Induction of type 1 diabetes by Kilham’s rat virus in diabetes resistant BB/Wor rats. Science254 :1010 eC1013,1991
Zipris D, Hillebrands J-L, Welsh RM, Rozing J, Xie JX, Mordes JP, Greiner DL, Rossini AA: Infections that induce autoimmune diabetes in BBDR rats modulate CD4+CD25+ T-cell populations. J Immunol170 :3592 eC3602,2003
Martin A-M, Blankenhorn EP, Maxson MN, Zhao M, Leif J, Mordes JP, Greiner DL: NoneCmajor histocompatibility complexeClinked diabetes susceptibility loci on chromosomes 4 and 13 in a backcross of the DP-BB/Wor rat to the WF rat. Diabetes48 :50 eC58,1999
Mordes JP, Leif J, Novak S, DeScipio C, Greiner DL, Blankenhorn EP: The iddm4 locus segregates with diabetes susceptibility in congenic WF. iddm4 rats. Diabetes51 :3254 eC3262,2002
Hornum L, DeScipio C, Markholst H, Troutman SA, Novak S, Leif J, Greiner D, Mordes JP, Blankenhorn EP: Comparative mapping of rat Iddm4 to segments on HSA7 and MMU6. Mamm Genome15 :53 eC61,2004
Butterfield RJ, Blankenhorn EP, Roper RJ, Zachary JF, Doerge RW, Teuscher C: Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis. Am J Pathol157 :637 eC645,2000
Ellerman KE, Richards CA, Guberski DL, Shek WR, Like AA: Kilham rat virus triggers T-celleCdependent autoimmune diabetes in multiple strains of rat. Diabetes45 :557 eC562,1996
Brodnicki TC, Quirk F, Morahan G: A susceptibility allele from a noneCdiabetes-prone mouse strain accelerates diabetes in NOD congenic mice. Diabetes52 :218 eC222,2003
McAleer MA, Reifsnyder P, Palmer SM, Prochazka M, Love JM, Copeman JB, Powell EE, Rodrigues NR, Prins JB, Serreze DV, DeLarato NH, Wicker LS, Peterson LB, Schork NJ, Todd JA, Leiter EH: Crosses of NOD mice with the related NON strain: a polygenic model for IDDM. Diabetes44 :1186 eC1195,1995
Elly C, Witte S, Zhang Z, Rosnet O, Lipkowitz S, Altman A, Liu YC: Tyrosine phosphorylation and complex formation of Cbl-b upon T-cell receptor stimulation. Oncogene18 :1147 eC1156,1999
Yokoi N, Komeda K, Wang HY, Yano H, Kitada K, Saitoh Y, Seino Y, Yasuda K, Serikawa T, Seino S: Cblb is a major susceptibility gene for rat type 1 diabetes mellitus. Nat Genet31 :391 eC394,2002
Brown DW, Welsh RM, Like AA: Infection of peripancreatic lymph nodes but not islets precedes Kilham rat virus-induced diabetes in BB/Wor rats. J Virol67 :5873 eC5878,1993
McKisic MD, Paturzo FX, Gaertner DJ, Jacoby RO, Smith AL: A nonlethal rat parvovirus infection suppresses rat T lymphocyte effector functions. J Immunol155 :3979 eC3986,1995
DeClercq E: Interferon induction by polynucleotides, modified polynucleotides, and polycarboxylates. Methods Enzymol78 :227 eC235,1981
Akiyama Y, Stevenson GW, Schlick E, Matsushima K, Miller PJ: Differential ability of human blood monocyte subsets to release various cytokines. J Leukocyte Biol37 :519 eC530,1985
Fresa KL, Korngold R, Murasko DM: Induction of natural killer cell activity of thoracic duct lymphocytes by polyinosinic-polycytidylic acid (poly(I:C)) or interferon. Cell Immunol91 :336 eC343,1985
Turner W, Chan SP, Chirigos MA: Stimulation of humoral and cellular antibody formation in mice by poly I:C. Proc Soc Exp Biol Med133 :334 eC338,1970
Davis CT, Blankenhorn EP, Murasko DM: Genetic variation in the ability of several strains of rats to produce interferon in response to polyriboinosinic-polyribocytodilic acid. Infect Immun43 :580 eC583,1984(Elizabeth P. Blankenhorn,)
2 Department of Medicine, University of Massachusetts, Worcester, Massachusetts
ABSTRACT
BBDR rats develop autoimmune diabetes only after challenge with environmental perturbants. These perturbants include polyinosinic:polycytidylic acid (poly I:C, a ligand of toll-like receptor 3), agents that deplete regulatory T-cell (Treg) populations, and a noneC-cell cytopathic parvovirus (Kilham rat virus [KRV]). The dominant diabetes susceptibility locus Iddm4 is required for diabetes induced by treatment with poly I:C plus Treg depletion. Iddm4 is penetrant in congenic heterozygous rats on the resistant WF background and is 79% sensitive and 80% specific as a predictor of induced diabetes. Surprisingly, an analysis of 190 (BBDR x WF)F2 rats treated with KRV after brief exposure to poly I:C revealed that the BBDR-origin allele of Iddm4 is necessary but not entirely sufficient for diabetes expression. A genome scan identified a locus on chromosome 17, designated Iddm20, that is also required for susceptibility to diabetes after exposure to KRV and poly I:C (logarithm of odds score 3.7). These data suggest that the expression of autoimmune diabetes is a complex process that requires both major histocompatibility complex genes that confer susceptibility and additional genes such as Iddm4 and Iddm20 that operate only in the context of specific environmental perturbants, amplifying the immune response and the rate of disease progression.
Type 1 diabetes results from inflammatory infiltration of pancreatic islets and selective -cell destruction. It is thought to be caused by environmental factors operating in a genetically susceptible host (1,2). Susceptibility loci include the major histocompatibility complex (MHC), a promoter polymorphism of the insulin gene, and an allelic variant of CTLA4 (3). Among candidate environmental perturbants, viral infection is one of the most likely (4). How genes interact with the environment to transform diabetes susceptibility into overt disease is unknown.
BBDR rats model virus-induced autoimmune diabetes remarkably well (5). They are phenotypically normal and, in clean housing, never develop diabetes. They do, however, become diabetic when challenged with environmental perturbants, including polyinosinic:polycytidylic acid (poly I:C) in combination with depletion of regulatory T-cells (Tregs) (6). Diabetes can also be induced in BBDR rats with Kilham rat virus (KRV), a noneC-cell cytopathic parvovirus (7). Naturally occurring KRV infection induces diabetes in 1% of animals; intentional infection with 107 plaque forming units (PFU) induces diabetes in 30% of BBDR rats (7). Infection with KRV following brief pretreatment with a low, subdiabetogenic dose of poly I:C (1 e/g daily for 3 days) leads to diabetes in 100% of animals (8). The effect is virus specific; H-1, which is 98% sequence identical, uniformly fails to induce diabetes (8).
In analyses of (BBDP x WF) x WF rats, we used poly I:C plus Treg depletion to map a locus on chromosome 4 (Iddm4) with significant linkage to diabetes (6,9), and we recently positioned Iddm4 in a 2.8-cM region (10). The BB- origin allele of Iddm4 is dominant and 79% sensitive and 80% specific as a predictor of diabetes induced by Treg depletion and poly I:C. A radiation hybrid map has assigned Iddm4 to a 6.3-Mb segment between PTN and ZYX at 7q32 in the human genome and to a 5.7-Mb segment between Ptn and Zyx in the mouse genome (11).
We now report a linkage analysis of 190 (BBDR x WF)F2 rats. It reveals that the BBDR-origin allele of Iddm4 is necessary but not entirely sufficient for diabetes expression in response to KRV infection. An additional gene or genes on chromosome 17 are necessary.
RESEARCH DESIGN AND METHODS
BBDR/Wor, WF.Iddm4, and WF.ART2a rats (all RT1u/u, ART2a) were obtained from colonies maintained by us. WF.Iddm4 congenic rats were generated by repetitive (BBDR/Wor x WF) x WF backcrosses using a marker-assisted selection protocol as described (10). They were studied at the N6 generation. WF.ART2a congenic rats were also developed by us and differ from ordinary WF animals in that they express the "a" rather than the "b" allotype of the ART2 T-cell alloantigen on chromosome 1 (10). For simplicity, we refer to them here as WF rats. An F2 intercross was bred from (BBDR x WF)F1 hybrids. Animals were housed in viral antibodyeCfree conditions, confirmed monthly to be serologically free of rat pathogens (10), and maintained in accordance with recommendations in the Guide for the Care and Use of Laboratory Animals (National Academy of Sciences, 1996).
Microsatellite and mapping analyses.
Genomic DNA was prepared as described (10) (online appendix Fig. 3 [available from http://diabetes.diabetesjournals.org]). Microsatellite markers were placed evenly throughout the 20 autosomes. The source of primers and positions of markers on the genetic map are given in online appendix Fig. 3. Primers were end labeled using 32P-ATP, used in a PCR reaction, and resolved by polyacrylamide gel electrophoresis as described (6). The position of markers on the genetic map was established by inspection of the dataset and conventional calculation methods to establish meiotic map distances, which are expressed in centimorgans (cM) or megabases (Mb) according to the rat genome sequence, June 2003 build (available at http://genome.ucsc.edu).
Linkage of diabetes with segregation of BBDR-origin alleles was evaluated by composite interval mapping (CIM) using model 6 of the Zmapqtl program in Windows QTL Cartographer v1.30 (available at statgen.ncsu.edu/qtlcart/cartographer.html). CIM combines classical interval mapping with multiple regression analysis, allowing for more precise quantitative trait loci (QTL) localization than classical interval mapping (12).
Treatment protocols.
KRV-UMass was propagated in normal rat kidney cells grown in Dulbecco’s minimal essential medium. Poly I:C (Sigma, St. Louis, MO) was dissolved in Dulbecco’s PBS, sterile filtered, and stored at eC20°C until used. Contaminating endotoxin concentration was <50 units/mg (Charles River Endosafe, Charleston, SC). In studies of KRV alone, rats of either sex 22eC28 days old were injected intraperitoneally with 107 PFU in a volume of 1 ml. In other experiments, rats 21eC25 days of age of either sex were injected intraperitoneally with poly I:C (1 e/g body wt on 3 consecutive days) and either not treated further or injected on the following day with KRV. Pretreatment with poly I:C was used because it increases the frequency of diabetes in KRV-treated BBDR rats from 30 to 100% (8). Animals were screened three times weekly for glycosuria (Tes-Tape; Eli Lilly, Indianapolis, IN). Diabetes was diagnosed on the basis of a plasma glucose concentration >11.1 mmol/l (OneTouch Ultra Glucometer; LifeScan, Milpitas, CA). For study of insulitis, pancreata were removed, fixed in formalin, and stained with hematoxylin and eosin. Insulitis was graded by a qualified pathologist on a scale of increasing intensity from 0 to 4+ as described (10).
RESULTS
Autoimmune diabetes induced by KRV and TLR3 ligation.
We first confirmed (8) that a significant fraction (41%) of parental BBDR rats become diabetic after infection with KRV alone, that none become diabetic in response to a 3-day course of poly I:C alone, and that 100% become diabetic in response to KRV after poly I:C (Table 1). We also confirmed (13) that WF rats resist diabetes induction in response to either KRV or KRV plus poly I:C (Table 1).
We next tested N6 generation WF.Iddm4 congenic rats (10) for disease susceptibility. To our surprise, we observed WF.Iddm4d rats to be uniformly resistant to diabetes in response to KRV infection either alone or after poly I:C, despite maintaining the expected degree of susceptibility to diabetes after treatment with poly I:C and Treg depletion (Table 1).
Autoimmune diabetes induced by KRV and TLR ligation segregates with Iddm4 and a second locus in (BBDR x WF)F2 rats.
To determine whether Iddm4 acts only in the presence of additional BBDR-origin genes, we generated (BBDR x WF)F1 progeny. We observed that all F1 rats were resistant to KRV alone, but 38% were susceptible to treatment with KRV plus poly I:C. To identify susceptibility genes, we then generated (BBDR x WF)F2 progeny and treated them with KRV plus poly I:C. Diabetes occurred in 59 of 190 animals (31%) in this segregating population and affected both males and females (Table 1). Looking first at the Iddm4 interval, we observed that diabetes occurred almost exclusively in animals with at least one BBDR-origin allele of Iddm4 (58 of 59 diabetic animals, Table 2). The presence of the BBDR allele of Iddm4 was 98% sensitive but only 31% specific in predicting susceptibility to diabetes, implying that at least one gene of BBDR origin is required for the expression of diabetes in response to infection. We therefore performed a genome-wide scan on this F2 cohort. The remaining genome was assessed for linkage using 144 markers on the 20 autosomes (online appendix Fig. 3).
Composite interval analysis of the linkage data is shown in Fig. 1. Iddm4, as expected, showed strong linkage to diabetes (logarithm of odds [LOD] >6.0 at 36 cM on chromosome 4). A second locus on chromosome 17 was linked to diabetes in the F2 population with an LOD score of 3.7. This locus has been designated Iddm20 by the curators of the Rat Genome Database (available at www.rgd.mcw.edu).
To determine the mode of inheritance and the interaction between these two loci, we analyzed the dataset using a life-table analysis. As shown in Fig. 2, the highest likelihood of diabetes onset occurs in animals in which the BBDR-origin allele of Iddm4 is homozygous or heterozygous and Iddm20 is homozygous.
Candidate gene analysis.
The genome-wide scan positioned the Iddm20 locus in a 1-LOD interval bounded by D17Rat61 (at 19.7 Mb) and D17Rat115 (at 27.7 Mb) (available at http://genome.ucsc.edu). To identify candidate genes within this interval, we constructed a preliminary map using the databases at UCSC and Ensembl (available at http://genome.ucsc.edu and http://www.ensembl.org). The genes in the Iddm20 region have their human orthologs on human chromosomes 5, 6, and 9 and on mouse chromosome 13. Of interest is a confirmed mouse diabetes QTL (Idd14) in this homologous region (14,15). Candidate genes in the Iddm20 interval are listed in online appendix Table 4.
Histology.
Histologic analysis of islets revealed nearly complete concordance of insulitis scores with diabetes phenotype. Among the 59 diabetic F2 animals, the mean insulitis score was 3.7 with 49 scored 4+ or end-stage insulitis. In contrast, among 127 nondiabetic rats with technically satisfactory specimens, the mean insulitis score was 0.3 with 111 (87%) being entirely normal and 8 of the remaining 16 exhibiting only 1+ insulitis. Exocrine pancreatitis was absent.
DISCUSSION
These data establish linkage of rat genotype to a form of environmental perturbation—infection—that is potentially important in the pathogenesis of autoimmunity. They confirm that Iddm4 is an exceptionally strong non-MHC determinant of susceptibility to autoimmune diabetes in the rat (6,9eC11). In previous studies of Iddm4, diabetes was induced by chronic treatment with poly I:C plus Treg depletion. The present data now extend the role of Iddm4 in diabetes pathogenesis to virus-induced disease expression. They also illuminate the complexity of environmental interaction with genetic susceptibility. The diabetogenic potential of Iddm4 is readily discernable in congenic rats treated with poly I:C and Treg depletion but is far less apparent in animals treated with KRV plus poly I:C unless additional BBDR genes are present. We have discovered at least one of these genes, designated Iddm20, on chromosome 17.
The Iddm20 interval (online appendix Table 3) contains at least one gene of particular interest: Syk. This gene is involved in T-cell receptoreCdependent signaling pathways and interacts with Cblb (16). This could be important because Cblb is a known rat diabetes susceptibility gene (17). Loss of function mutations in Cblb lead to activation of autoreactive diabetogenic T-cells in the absence of full costimulation (17).
Iddm20, like Iddm4, appears to act as a genetic dominant with incomplete penetrance. There is clear disease-promoting activity in the Iddm20 heterozygote. In the poly I:C plus Treg system, 70% of both WF.Iddm4d/w heterozygotes and WF.Iddm4d/d homozygotes become diabetic (10). In the KRV plus poly I:C model, homozygosity for diabetogenic alleles at the Iddm20 locus increases the penetrance of diabetes in Iddm4d/d rats from 25% (in Iddm20w/w animals) to 56%, and it increases penetrance in Iddm4d/w rats from 11 to 59%. We therefore regard Iddm20 as a modifier of the Iddm4 locus.
The mechanisms by which poly I:C and KRV infection act to induce diabetes in genetically susceptible rats are not yet known. We speculate that Iddm4, Iddm20, or both define a strain-specific response of BBDR rats to KRV infection. KRV is known to infect lymphocytes in the pancreatic lymph nodes (but not the islets) of BBDR rats (18). More recent studies have revealed that KRV also causes a decrease in splenic CD4+CD25+ Treg cells in both BBDR and normal WF rats (8). In adult LEW rats, KRV-UMass infection is associated with several potentially important effects on both CD4+ and CD8+ T-cell populations (19) but whether allelic variations in Iddm4 or Iddm20 regulate those responses is not yet known. By itself, KRV infection typically induces diabetes in 30eC40% of BBDR/Wor rats (8). Pretreatment poly I:C, at a dose that is itself incapable of inducing disease, dramatically increases the penetrance of diabetes (8). The mechanism of this synergy is not clear but is likely to relate to innate immunity because poly I:C is a ligand of toll-like receptor 3 and a potent inducer of type I interferon production by various cells (20) and interleukin-1 production by monocytes (21). It also activates natural killer cells (22) and B-cells (23). In rats, it has been shown that interferon production in response to poly I:C varies substantially in different inbred strains (24), an effect that is presumably genetically determined. It will be of interest to determine whether Iddm4 and/or Iddm20 is a determinant of the magnitude of the immune response to poly I:C.
ACKNOWLEDGMENTS
This study was supported in part by grants DK49106 (to D.L.G., J.P.M., and E.P.B.), DK 36024 (to D.L.G.), DK25306 (to J.P.M.), and Center Grant DK32520 from the National Institutes of Health. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.
We thank Dr. Michael Appel for scoring histology specimens, Michael Bates and Deborah Mullen for technical assistance, and Dennis Guberski for logistic support.
FOOTNOTES
Additional information for this article can be found in an online appendix at http://diabetes.diabetesjournals.org.
KRV, Kilham rat virus; MHC, major histocompatibility complex; poly I:C, polyinosinic:polycytidylic acid; QTL, quantitative trait loci; Treg, regulatory T-cell
REFERENCES
Hawa MI, Beyan H, Buckley LR, Leslie RDG: Impact of genetic and non-genetic factors in type 1 diabetes. Am J Med Genet115 :8 eC17,2002
kerblom HK, Vaarala O, Hyty H, Ilonen J, Knip M: Environmental factors in the etiology of type 1 diabetes. Am J Med Genet115 :18 eC29,2002
Anjos S, Polychronakos C: Mechanisms of genetic susceptibility to type I diabetes: beyond HLA. Mol Genet Metab81 :187 eC195,2004
Yoon J-W, Jun H-S: Role of viruses in the pathogenesis of type 1 diabetes mellitus. In Diabetes mellitus: A fundamental and clinical text. LeRoith D, Taylor SI, Olefsky JM, Eds. Philadelphia, Lippincott Williams & Wilkins,2004 , p.575 eC590
Mordes JP, Bortell R, Blankenhorn EP, Rossini AA, Greiner DL: Rat models of type 1 diabetes: Genetics, environment, and autoimmunity. ILAR J45 :278 eC291,2004
Martin A-M, Maxson MN, Leif J, Mordes JP, Greiner DL, Blankenhorn EP: Diabetes-prone and diabetes-resistant BB rats share a common major diabetes susceptibility locus, iddm4: additional evidence for a "universal autoimmunity locus" on rat chromosome 4. Diabetes48 :2138 eC2144,1999
Guberski DL, Thomas VA, Shek WR, Like AA, Handler ES, Rossini AA, Wallace JE, Welsh RM: Induction of type 1 diabetes by Kilham’s rat virus in diabetes resistant BB/Wor rats. Science254 :1010 eC1013,1991
Zipris D, Hillebrands J-L, Welsh RM, Rozing J, Xie JX, Mordes JP, Greiner DL, Rossini AA: Infections that induce autoimmune diabetes in BBDR rats modulate CD4+CD25+ T-cell populations. J Immunol170 :3592 eC3602,2003
Martin A-M, Blankenhorn EP, Maxson MN, Zhao M, Leif J, Mordes JP, Greiner DL: NoneCmajor histocompatibility complexeClinked diabetes susceptibility loci on chromosomes 4 and 13 in a backcross of the DP-BB/Wor rat to the WF rat. Diabetes48 :50 eC58,1999
Mordes JP, Leif J, Novak S, DeScipio C, Greiner DL, Blankenhorn EP: The iddm4 locus segregates with diabetes susceptibility in congenic WF. iddm4 rats. Diabetes51 :3254 eC3262,2002
Hornum L, DeScipio C, Markholst H, Troutman SA, Novak S, Leif J, Greiner D, Mordes JP, Blankenhorn EP: Comparative mapping of rat Iddm4 to segments on HSA7 and MMU6. Mamm Genome15 :53 eC61,2004
Butterfield RJ, Blankenhorn EP, Roper RJ, Zachary JF, Doerge RW, Teuscher C: Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis. Am J Pathol157 :637 eC645,2000
Ellerman KE, Richards CA, Guberski DL, Shek WR, Like AA: Kilham rat virus triggers T-celleCdependent autoimmune diabetes in multiple strains of rat. Diabetes45 :557 eC562,1996
Brodnicki TC, Quirk F, Morahan G: A susceptibility allele from a noneCdiabetes-prone mouse strain accelerates diabetes in NOD congenic mice. Diabetes52 :218 eC222,2003
McAleer MA, Reifsnyder P, Palmer SM, Prochazka M, Love JM, Copeman JB, Powell EE, Rodrigues NR, Prins JB, Serreze DV, DeLarato NH, Wicker LS, Peterson LB, Schork NJ, Todd JA, Leiter EH: Crosses of NOD mice with the related NON strain: a polygenic model for IDDM. Diabetes44 :1186 eC1195,1995
Elly C, Witte S, Zhang Z, Rosnet O, Lipkowitz S, Altman A, Liu YC: Tyrosine phosphorylation and complex formation of Cbl-b upon T-cell receptor stimulation. Oncogene18 :1147 eC1156,1999
Yokoi N, Komeda K, Wang HY, Yano H, Kitada K, Saitoh Y, Seino Y, Yasuda K, Serikawa T, Seino S: Cblb is a major susceptibility gene for rat type 1 diabetes mellitus. Nat Genet31 :391 eC394,2002
Brown DW, Welsh RM, Like AA: Infection of peripancreatic lymph nodes but not islets precedes Kilham rat virus-induced diabetes in BB/Wor rats. J Virol67 :5873 eC5878,1993
McKisic MD, Paturzo FX, Gaertner DJ, Jacoby RO, Smith AL: A nonlethal rat parvovirus infection suppresses rat T lymphocyte effector functions. J Immunol155 :3979 eC3986,1995
DeClercq E: Interferon induction by polynucleotides, modified polynucleotides, and polycarboxylates. Methods Enzymol78 :227 eC235,1981
Akiyama Y, Stevenson GW, Schlick E, Matsushima K, Miller PJ: Differential ability of human blood monocyte subsets to release various cytokines. J Leukocyte Biol37 :519 eC530,1985
Fresa KL, Korngold R, Murasko DM: Induction of natural killer cell activity of thoracic duct lymphocytes by polyinosinic-polycytidylic acid (poly(I:C)) or interferon. Cell Immunol91 :336 eC343,1985
Turner W, Chan SP, Chirigos MA: Stimulation of humoral and cellular antibody formation in mice by poly I:C. Proc Soc Exp Biol Med133 :334 eC338,1970
Davis CT, Blankenhorn EP, Murasko DM: Genetic variation in the ability of several strains of rats to produce interferon in response to polyriboinosinic-polyribocytodilic acid. Infect Immun43 :580 eC583,1984(Elizabeth P. Blankenhorn,)